Ending the Pandemic: How Behavioural Science Can Help Optimize Global COVID-19 Vaccine Uptake.

COVID-19 behaviour change behavioural science vaccine acceptance vaccine hesitancy

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
22 Dec 2021
Historique:
received: 12 11 2021
revised: 14 12 2021
accepted: 20 12 2021
entrez: 22 1 2022
pubmed: 23 1 2022
medline: 23 1 2022
Statut: epublish

Résumé

Governments, public health officials and pharmaceutical companies have all mobilized resources to address the COVID-19 pandemic. Lockdowns, social distancing, and personal protective behaviours have been helpful but have shut down economies and disrupted normal activities. Vaccinations protect populations from COVID-19 and allow a return to pre-pandemic ways of living. However, vaccine development, distribution and promotion have not been sufficient to ensure maximum vaccine uptake. Vaccination is an individual choice and requires acceptance of the need to be vaccinated in light of any risks. This paper presents a behavioural sciences framework to promote vaccine acceptance by addressing the complex and ever evolving landscape of COVID-19. Effective promotion of vaccine uptake requires understanding the context-specific barriers to acceptance. We present the AACTT framework (Action, Actor, Context, Target, Time) to identify the action needed to be taken, the person needed to act, the context for the action, as well as the target of the action within a timeframe. Once identified a model for identifying and overcoming barriers, called COM-B (Capability, Opportunity and Motivation lead to Behaviour), is presented. This analysis identifies issues associated with capability, opportunity and motivation to act. These frameworks can be used to facilitate action that is fluid and involves policy makers, organisational leaders as well as citizens and families.

Identifiants

pubmed: 35062668
pii: vaccines10010007
doi: 10.3390/vaccines10010007
pmc: PMC8777721
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Emerg Infect Dis. 2020 Jul;26(7):1470-1477
pubmed: 32255761
Pediatrics. 2014 Apr;133(4):e835-42
pubmed: 24590751
Vaccine. 2021 Jun 11;39(26):3520-3527
pubmed: 34023136
Vaccine. 2021 Dec 3;39(49):7158-7165
pubmed: 34774363
Vaccine. 2015 Aug 14;33(34):4176-9
pubmed: 25896376
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
Acad Pediatr. 2021 May-Jun;21(4S):S24-S29
pubmed: 33958087
Prev Med. 2021 Apr;145:106421
pubmed: 33422575
Psychol Sci Public Interest. 2017 Dec;18(3):149-207
pubmed: 29611455
Lancet Public Health. 2021 Jun;6(6):e416-e427
pubmed: 33991482
Health Commun. 2020 Dec;35(14):1718-1722
pubmed: 33124475
Vaccine. 2020 Jan 22;38(4):709-711
pubmed: 31836257
BMC Public Health. 2018 Jan 30;18(1):196
pubmed: 29378545
Vaccines (Basel). 2020 Dec 30;9(1):
pubmed: 33396832
Pers Individ Dif. 2021 Apr;172:110590
pubmed: 33518869
Health Secur. 2020 Jul/Aug;18(4):338-344
pubmed: 32706599
Vaccine. 2020 Jan 16;38(3):470-481
pubmed: 31767469
J Infect. 2020 Jun;80(6):e32-e33
pubmed: 32209383
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Hum Vaccin Immunother. 2021 Sep 2;17(9):2940-2945
pubmed: 33998949
JAMA. 2021 Feb 9;325(6):534-535
pubmed: 33404585
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
BMC Health Serv Res. 2017 Sep 26;17(1):681
pubmed: 28950899
Nat Hum Behav. 2020 May;4(5):451-459
pubmed: 32377018
Int J Prod Econ. 2021 Sep;239:108193
pubmed: 34121813
Expert Rev Vaccines. 2021 Aug;20(8):959-973
pubmed: 34192985
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
JAMA Netw Open. 2021 Mar 1;4(3):e215344
pubmed: 33755164
Perspect Psychol Sci. 2021 Mar;16(2):191-203
pubmed: 33501900
Health Psychol Rev. 2015;9(3):323-44
pubmed: 25104107
Implement Sci. 2019 Dec 5;14(1):102
pubmed: 31806037
Nicotine Tob Res. 2020 Jan 27;22(1):96-103
pubmed: 30053141
Vaccine. 2016 Jun 14;34(28):3235-42
pubmed: 27155491
Nat Med. 2021 May;27(5):749-752
pubmed: 33972794
Proc Natl Acad Sci U S A. 2021 Aug 10;118(32):
pubmed: 34315824
Vaccine. 2012 Jul 6;30(32):4733-43
pubmed: 22643216
Sci Rep. 2021 Aug 9;11(1):16144
pubmed: 34373540
Nat Med. 2021 Feb;27(2):205-211
pubmed: 33469205
Vaccines (Basel). 2021 Jun 17;9(6):
pubmed: 34204379
Vaccine. 2016 Feb 17;34(8):1018-24
pubmed: 26672676
Annu Rev Public Health. 2021 Apr 1;42:175-191
pubmed: 33798403
Annu Rev Public Health. 2014;35:47-63
pubmed: 24641554
Infect Control Hosp Epidemiol. 2021 Jul 15;:1-2
pubmed: 34261568

Auteurs

Michael Vallis (M)

Department of Family Medicine, Dalhousie University, Halifax, NS B3J 3T4, Canada.

Simon Bacon (S)

Department of Health, Kinesiology and Applied Physiology, Concordia University, Montreal, QC H4B 1R6, Canada.
Montreal Behavioural Medicine Centre, Montreal, QC H4J 1C5, Canada.

Kim Corace (K)

Department of Psychiatry, University of Ottawa, Ottawa, ON K1Z 7K4, Canada.
Institute of Mental Health Research, University of Ottawa, Ottawa, ON K1Z 7K4, Canada.

Keven Joyal-Desmarais (K)

Department of Health, Kinesiology and Applied Physiology, Concordia University, Montreal, QC H4B 1R6, Canada.
Montreal Behavioural Medicine Centre, Montreal, QC H4J 1C5, Canada.

Sherri Sheinfeld Gorin (S)

Department of Family Medicine, University of Michigan, Ann Arbour, MI 48104, USA.

Stefania Paduano (S)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.

Justin Presseau (J)

Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, ON K1Y 4E9, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON K1G 5Z3, Canada.

Joshua Rash (J)

Department of Psychology, Memorial University of Newfoundland, St. John's, NF A1B 3X9, Canada.

Abebaw Mengistu Yohannes (A)

Department of Physical Therapy, Azusa Pacific University, Azusa, CA 91720, USA.

Kim Lavoie (K)

Montreal Behavioural Medicine Centre, Montreal, QC H4J 1C5, Canada.
Department of Psychology, University of Quebec at Montreal (UQAM), Montreal, QC H2X 3P2, Canada.

Classifications MeSH